Pet Diabetes Care Market Trends, Growth & Forecast 2025-2033

Market Overview:

The pet diabetes care market is experiencing rapid growth, driven by rising pet ownership and humanization, advancements in veterinary technology, and increased awareness of pet health. According to IMARC Group's latest research publication, "Pet Diabetes Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global pet diabetes care market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/pet-diabetes-care-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Pet Diabetes Care Market

• Rising Pet Ownership and Humanization

More people are welcoming pets into their homes, treating them like family members, which boosts demand for advanced pet healthcare. In the U.S., over 66% of households own a pet, with millions prioritizing their animals’ well-being, according to the American Veterinary Medical Association. This trend drives pet owners to invest in diabetes care devices like glucose monitors and insulin pens to manage their pets’ health. Companies like Zoetis and Merck Animal Health are capitalizing on this, offering tailored diabetes solutions. Government initiatives, such as the FDA’s Center for Veterinary Medicine, ensure safe, effective treatments, encouraging innovation. This shift toward viewing pets as companions fuels spending on specialized care, significantly expanding the market for pet diabetes management tools.

• Advancements in Veterinary Technology

Innovations in pet diabetes care devices, like continuous glucose monitors and smart insulin delivery systems, are making management easier and more precise. For example, Abbott’s FreeStyle Libre, adapted for pets, allows real-time glucose tracking, reducing stress for animals and owners. Veterinary clinics are adopting these tools, with over 50% of U.S. clinics now using advanced diagnostics, per industry reports. Companies like Medtronic are developing pet-specific insulin pumps, enhancing treatment outcomes. Government support, such as the NIH’s funding for veterinary research, accelerates these advancements. These technologies improve accuracy and convenience, encouraging pet owners to invest in high-quality care, which drives market growth as more solutions become accessible and effective for managing pet diabetes.

• Increased Awareness of Pet Health

Pet owners are becoming more educated about animal health, leading to earlier diabetes detection and treatment. Educational campaigns by groups like the American Animal Hospital Association reach millions, emphasizing regular vet checkups. Over 1 in 300 dogs and 1 in 230 cats are diagnosed with diabetes, per Vetsource, prompting owners to seek care solutions. Companies like Purina are partnering with veterinary groups to promote diabetes awareness through screenings and diet plans. Government-backed programs, such as the USDA’s animal health initiatives, support public education efforts. This growing awareness encourages proactive care, increasing demand for glucose monitoring devices and insulin therapies, which fuels the pet diabetes care market as owners prioritize their pets’ long-term health.

Key Trends in the Pet Diabetes Care Market

• Growth of Telehealth and Remote Monitoring

Telehealth is transforming pet diabetes care by enabling remote monitoring and consultations. Platforms like Vetster connect pet owners with veterinarians, with over 10,000 virtual visits monthly, per industry data. Devices like i-SENS glucose monitors integrate with apps, allowing owners to track their pet’s glucose levels and share data with vets in real time. This trend reduces clinic visits, saving time and stress. Companies like Zoetis are investing in telehealth-compatible devices, enhancing accessibility. Veterinary clinics are adopting these tools, with 30% of U.S. clinics offering telemedicine, per recent surveys. This shift empowers owners to manage diabetes proactively, improving pet outcomes and driving demand for connected care solutions in the market.

• Personalized Pet Diabetes Treatments

Customized diabetes care plans for pets are gaining traction, tailored to individual animal needs. For instance, Merck Animal Health’s insulin therapies, like Vetsulin, are adjusted based on pet size and condition, with over 500,000 doses distributed annually. Advances in genetic testing allow vets to design precise diet and insulin regimens, improving outcomes. Clinics report a 20% increase in personalized treatment plans, per veterinary journals. Companies like Boehringer Ingelheim are developing targeted therapies, supported by research grants from organizations like the Morris Animal Foundation. This trend enhances treatment effectiveness, encouraging owners to invest in specialized care, which boosts the market for innovative diabetes management products and services.

• Partnerships and Collaborative Care Programs

Collaborations between companies and veterinary groups are reshaping pet diabetes care. Merck Animal Health, Zoetis, and Purina’s Diabetes Pet Care Alliance screens thousands of pets annually, promoting early diagnosis. These partnerships offer free resources, like glucose test kits, reaching over 5,000 clinics, per company reports. Government programs, such as the AVMA’s outreach initiatives, support these efforts by funding awareness campaigns. Such alliances streamline access to care, combining diagnostics, treatments, and education. For example, Zoetis’s Vetscan analyzers are now used in 40% of partnered clinics, per industry data. These collaborations enhance care quality, drive device adoption, and expand the market by making diabetes management more accessible and effective for pet owners.

We explore the factors driving the growth of the market, including technological advancements, consumer behaviors, and regulatory changes, along with emerging pet diabetes care market trends.

Leading Companies Operating in the Global Pet Diabetes Care Industry:

• AccuBioTech Co., Ltd
• Allison Medical Inc.
• Boehringer Ingelheim Animal Health USA Inc.
• Elanco
• i-SENS USA
• Med Trust
• Merck & Co., Inc.
• UltiMed, Inc.
• Virbac
• Zoetis Services LLC

Pet Diabetes Care Market Report Segmentation:

By Solution:

• Treatment
• Glucose Monitoring Devices

Treatment, including insulin and specialized diets, leads the pet diabetes care market due to its critical role in managing the condition.

By Animal Type:

• Dogs
• Cats

Dogs dominate the market, driven by higher diabetes prevalence and increased owner awareness of tailored care needs.

By Distribution Channel:

• Veterinary Hospitals and Clinics
• Retail Pharmacies
• Online Stores

Veterinary hospitals and clinics hold the largest share, offering specialized diabetes care and essential products.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the pet diabetes care market, followed by Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302